These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4020537)

  • 1. A reevaluation of psychotomimetic amphetamine derivatives in humans.
    Cassels BK; Gómez-Jeria JS
    J Psychoactive Drugs; 1985; 17(2):129-30. PubMed ID: 4020537
    [No Abstract]   [Full Text] [Related]  

  • 2. Profiles of psychedelic drugs: 10. DOB.
    Shulgin A
    J Psychoactive Drugs; 1981; 13(1):99. PubMed ID: 7277091
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of substituted-amphetamine hallucinogens using the cat limb flick model.
    Rusterholz DB; Spratt JL; Long JP; Barfknecht CF
    Commun Psychopharmacol; 1977; 1(6):589-92. PubMed ID: 608329
    [No Abstract]   [Full Text] [Related]  

  • 4. Congeners of DOM: effect of distribution of the evaluation of pharmacologic data.
    Barfknecht CF; Caputo JF; Tobin MB; Dyer DC; Standirdge RT; Howell HG; Goodwin WR; Partyka RA; Gylys JA; Cavanagh RL
    NIDA Res Monogr; 1978; (22):16-26. PubMed ID: 101880
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulfur analogues of psychotomimetic agents. 2. Analogues of (2,5-dimethoxy-4-methylphenyl)-and (2,5-dimethoxy-4-ethylphenyl)isopropylamine.
    Jacob P; Shulgin AT
    J Med Chem; 1983 May; 26(5):746-52. PubMed ID: 6842515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]DOB: a specific agonist radioligand for 5-HT2 serotonin receptors.
    Titeler M; Herrick K; Lyon RA; McKenney JD; Glennon RA
    Eur J Pharmacol; 1985 Oct; 117(1):145-6. PubMed ID: 4085543
    [No Abstract]   [Full Text] [Related]  

  • 7. The behavioral effects of 2,5-dimethoxy-4-alkyl amphetamines.
    Morin RD; Benington F; Mitchell SR; Beaton JM; Bradley RJ; Smythies JR
    Experientia; 1975 Jan; 31(1):93-5. PubMed ID: 234850
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM) on operant behavior: interactions with other neuroactive agents.
    Commissaris RL; Semeyn DR; Moore KE; Rech RH
    Commun Psychopharmacol; 1980; 4(5):393-404. PubMed ID: 6120791
    [No Abstract]   [Full Text] [Related]  

  • 9. QSAR studies on psychotomimetic phenylalkylamines.
    Gupta SP; Handa A; Bindal MC; Singh P
    Arzneimittelforschung; 1983; 33(8):1089-90. PubMed ID: 6685483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the identification of psychotropic substances. VI. Preparation and various analytical data of reference standards of some hallucinogens, 2,5-dimethoxy-4-methylamphetamine (STP), 2,5-dimethoxy-4-bromoamphetamine (DOB) and 2,5-dimethoxy-4-ethylamphetamine (DOET)].
    Shimamine M; Takahashi K; Nakahara Y
    Eisei Shikenjo Hokoku; 1989; (107):113-9. PubMed ID: 2636911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenethylamine hallucinogens in the locus coeruleus: potency of action correlates with rank order of 5-HT2 binding affinity.
    Rasmussen K; Glennon RA; Aghajanian GK
    Eur J Pharmacol; 1986 Dec; 132(1):79-82. PubMed ID: 3816969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral changes induced by 2,5-dimethoxy 4-methyl-amphetamine (DOM, STP) in primate dyads.
    Tyler CB; Schlemmer RF; Narasimhachari N; Davis JM
    Commun Psychopharmacol; 1978; 2(4):337-42. PubMed ID: 103677
    [No Abstract]   [Full Text] [Related]  

  • 13. Hallucinogens as a discriminative stimuli: generalization of DOM to a 5-methoxy-N, N-dimethyltryptamine stimulus.
    Glennon RA; Rosecrans JA; Young R; Gaines J
    Life Sci; 1979 Mar; 24(11):993-7. PubMed ID: 286864
    [No Abstract]   [Full Text] [Related]  

  • 14. Further studies on BL-3912A: effects on avoidance behavior of rats with low baselines and on reaction thresholds to electric footshock.
    Tilson HA; Chamberlain JH; Gylys JA
    Pharmacol Biochem Behav; 1977 Jun; 6(6):627-30. PubMed ID: 263545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of psychotomimetics on vascular strips: studies of methoxylated amphetamines and optical isomers of 2,5-dimethoxy-4-methylamphetamine and 2,5-dimethoxy-4-bromoamphetamine.
    Cheng HC; Long JP; Nichols DE; Barfknecht CF
    J Pharmacol Exp Ther; 1974 Jan; 188(1):114-23. PubMed ID: 4809263
    [No Abstract]   [Full Text] [Related]  

  • 16. Resolution and absolute configuration of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, a potent hallucinogen analogue.
    Nichols DE; Woodard R; Hathaway BA; Lowy MT; Yom KW
    J Med Chem; 1979 Apr; 22(4):458-60. PubMed ID: 430485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of delta9-tetrahydrocannabinol & 2, 5-dimethoxy-4-methylamphetamine on rat sexual dominance behavior.
    Uyeno ET
    Proc West Pharmacol Soc; 1976; 19():369-72. PubMed ID: 996008
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of chirality on serotonin receptor affinity.
    Glennon RA
    Life Sci; 1979 Apr; 24(16):1487-92. PubMed ID: 470548
    [No Abstract]   [Full Text] [Related]  

  • 19. LSD or DOB?
    Davis WM
    Am J Psychiatry; 1982 Dec; 139(12):1649. PubMed ID: 7149079
    [No Abstract]   [Full Text] [Related]  

  • 20. Bromo-DMA: new hallucinogenic drug.
    Delliou D
    Med J Aust; 1980 Jan; 1(2):83. PubMed ID: 7360100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.